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Abstract Joubert syndrome (JBTS) is an autosomal re-
cessive multisystem disease characterized by cerebellar
vermis aplasia, mental retardation, muscular hypotonia,
an irregular breathing pattern in the neonatal period and
abnormal eye movements. Some individuals have pro-
gressive renal failure characterized by nephronophthisis
(NPHP) and/or retinal dystrophy. Homozygous deletions
of NPHP1 on chromosome 2q13 have been identified in
individuals with NPHP-associated JBTS. Recently, mu-
tations in AHI1 on chromosome 6q23.3 were found in
JBTS patients without NPHP. Here, by direct sequencing,
we identify novel truncating mutations within AHI1 in
affected patients from two families. One patient had the
association of JBTS and NPHP with chronic renal failure.
This is the first report of AHI1 mutations causing JBTS
associated with NPHP, confirming the clinical and ge-
netic heterogeneity of NPHP.
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Introduction
Joubert syndrome (JBTS) is a rare autosomal recessive
multisystem disorder characterized by aplasia of the cer-
ebellar vermis, ataxia, abnormal eye movements, an ab-
normal breathing pattern in the neonatal period and psy-
chomotor mental retardation [1, 2, 3]. On MRI brain
imaging JBTS is characterized by a typical radiological
finding, termed as “molar tooth sign” (MTS). This reflects
a complex midbrain and hindbrain malformation con-
sisting of an increased interpeduncular distance of the
pontomesencephalic junction, cerebellar vermis aplasia
and thickened, straight and elongated superior cerebellar
peduncles [4, 5, 6]. The abnormal eye movements may
comprise oculomotor apraxia (OMA) type Cogan, or
difficulty with smooth eye pursuits and horizontal sac-
cades with jerking head thrusting and nystagmus [7]. A
related disorder has also been termed cerebello-oculo-
renal syndrome (CORS) [4, 8]. Some cases of JBTS may
be associated with nephronophthisis and retinal dystrophy
or retinal coloboma [3]. To date, two underlying gene
defects in patients with JBTS have been described. Ho-
mozygous NPHP1 deletions on chromosome 2q13 have
been reported in two cases of JBTS associated with
nephronophthisis [9]. However, it has been noted that
NPHP1 deletions are not a common cause of JBTS [10].
More recently, mutations in AHI1 on chromosome 6q23.3
were described in patients with JBTS, but without any
evidence of renal involvement [11, 12]. In addition to
these known gene defects, two loci have been mapped to
9q34.3 [13] and 11p12-q13.3 [14, 15]. Another putative
locus was suggested by the detection of a chromosome
17p11 deletion in a patient with Smith-Magenis syndrome
and a JBTS phenotype [16]. Here we report three novel
mutations in AHI1 including, for the first time, the asso-
ciation of JBTS with NPHP.
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Criteria for Joubert syndrome were based on the following clinical
hallmarks: presence of cerebellar vermis aplasia, cerebellar ataxia,
psychomotor developmental delay, nystagmus and oculomotor
apraxia. The patients also had NPHP by clinical history and by
renal biopsy in patient II-4 from family F799. Venous blood sam-
ples from family members were obtained after informed consent.
Genomic DNA was prepared according to standard methods.
NPHP1 deletions were excluded by Southern-blot analysis and
haplotype analysis (data not shown). In four JBTS individuals from
consanguineous families known to be homozygous for mi-
crosatellite markers across the AHI1 gene region [17], PCR of all
coding sequences and the corresponding exon-intron boundaries
of AHI1 where performed for mutational analysis. Primer se-
quences were determined using the UCSC sequence (http://ge-
nome.ucsc.edu/cgi-bin/hgGateway) and Primer3 software (http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). PCR prod-
ucts were purified (Marligen Biosciences) prior to direct sequenc-
ing (Genetic Analyzer 3700, Applied Biosystems). An additional
20 JBTS individuals from non-consanguineous families were also
screened. Ninety-six healthy individuals were screened as negative
controls for each novel AHI1 mutation.
Results
Homozygosity mapping in F799
Previous haplotyping data from a total genome search re-
vealed four consanguineous families (F799, F700, F427
and F216) with JBTS that were homozygous at the AHI1
gene locus on chromosome 6q23.3 [17]. High-resolution
haplotyping using 15 microsatellite markers was performed
in these families. A region of homozygosity of more than
27 Mb was confirmed in family F799, delimited by
flanking markers D6S303 and D6S1704 (Fig. 1). However,
regions of homozygosity were found to be interrupted by
heterozygous markers in consanguineous families F700,
F427 and F216, excluding them from this locus.
Mutational analysis of the AHI1 gene
Mutational analysis was performed by exon PCR cover-
ing all coding sequences and the corresponding exon-in-
tron boundaries of the AHI1 gene in families F799, F700,
F427 and F216. Exon PCR and direct sequencing in F799
revealed a homozygous single T nucleotide insertion
(2369insT) within exon 16 in both affected siblings (II-2
and II-4) resulting in a frame shift and a subsequent stop
codon at amino acid 791 (Fig. 2). Segregation of the
mutation was demonstrated with the mother and unaf-
fected siblings II-1 and II-3 showing a heterozygous T
nucleotide insertion.
AHI1 mutations were not detected in families F700,
F427 and F216. Direct sequencing confirmed a lack of
homozygosity in these families, revealing heterozygous
intronic single-nucleotide polymorphisms (SNPs) within
sequencing PCR amplicons (data not shown). Additional
screening for AHI1 mutations in 20 additional individuals
with JBTS revealed two compound heterozygous muta-
tions within exon 6 of AHI1 in family F400 (Fig. 2). The
first mutation is a 324 heterozygous nucleotide deletion
(365-688del) leading to an inframe deletion of 108 amino
acids. The latter is a single A nucleotide insertion at po-
sition 444 leading to a frame shift and stop codon at
amino acid 149. All mutations were absent from 96
healthy control individuals.
Fig. 1 Haplotyping and homo-
zygosity mapping in F799. Pa-
ternal haplotypes are drawn to
the left, and maternal haplo-
types to the right. Markers on
chromosome 6 ordered from top
to bottom are centromeric to
telomeric. Homozygous regions
in each affected individual are
boxed. The position of AHI1 is
depicted by an arrow. Black
symbols indicate individuals
with affected status and white
symbols indicate unaffected in-
dividuals; circles denote fe-
males and squares denote males
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Clinical features in JBTS patients with AHI1 mutations
Family F799 originated from Pakistan. The affected in-
dividuals II-2 and II-4 were children of a consanguineous
marriage whose parents were third degree cousins. The
clinical features of both affected males in F799 included
cerebellar ataxia, psychomotor developmental delay,
nystagmus and oculomotor apraxia. The youngest sibling
(II-4) had a salt and water-losing nephropathy leading to
end-stage renal failure by the age of 16 years. Corti-
comedullary cysts were revealed on renal ultrasound, and
a renal biopsy demonstrated changes consistent with
nephronophthisis. The second affected sibling (II-2) had
no renal symptoms, in particular no polyuria, and had not
developed renal insufficiency by 20 years of age. How-
ever, this does not exclude a milder form of nephron-
ophthisis in this patient. Siblings II-1 and II-3 remain
healthy. Patient II-1 of family F400, of unknown ethnic
origin, had JBTS associated with coloboma with no
clinical evidence of nephronophthisis and no documented
renal impairment. Additional clinical data, including renal
ultrasound, were unavailable.
Discussion
We have detected, by direct mutational analysis in three
patients, three novel mutations in AHI1, including one
patient with NPHP-associated JBTS, one patient with
JBTS without renal involvement and one patient with
JBTS associated with coloboma. AHI1 is highly expressed
in human brain and kidney [12]. Within the brain, there is
AHI1 mRNA expression in both the cerebellum and ce-
rebral cortex [12] consistent with the marked cerebellar
ataxia seen JBTS patients. The AHI1 protein, also known
as Jouberin, possesses several distinct protein domains,
which include one coiled-coil, six WD40 domains and
one SH3 domain. Based on these domains, a role for
Jouberin as an adapter protein for protein-protein inter-
actions has been postulated [11].
Mutations in AHI1 have previously been described
only in JBTS patients without a renal phenotype. Some of
these patients had evidence of additional central nervous
system abnormalities that included polymicrogyria [11].
These published mutations include two nonsense muta-
tions, R351X and R435X, and a missense mutation
Fig. 2 Identification of three novel AHI1 mutations in patients with
JBTS. A AHI1 mutations detected in F400 and F799 with JBTS.
Sequence traces (nucleotides and respective codon) are shown for
affected individuals (top) and healthy controls (below). Compound
heterozygous mutations are marked with a bracket. *Denotes a
premature stop codon. Note that double sequence in the mutated
allele (444insA,fs) of F400 II-1 does not reflect the wild type allele
since the other allele carries another mutation (365-688del) within
the same exon. B Exon structure of human AHI1 cDNA. Positions
of start codon (ATG) in exon 3 and of stop codon (TAG) in exon 28
are indicated. C Nucleotide changes and (D) corresponding amino
acid changes are shown in boxes. E Representations of AHI1
(Jouberin) protein motifs are drawn to scale in relation to exon
structure. Positions of the mutations detected are indicated by ar-
rows. CC coiled-coil domain; WD40 WD40 domain; SH3 src ho-
mology-3 domain
34
V443D described by Ferland et al. [12]. The same mis-
sense mutation was also independently reported by Dix-
on-Salazar et al., in addition to two further frame shift
mutations leading to truncations at codons 270 and 408,
respectively [11]. Thus, four truncating mutations were
previously reported, leading to a loss of WD40 domains
and SH3 domain regions at the C-terminus of the protein.
All of these mutations were reported in JBTS patients
without NPHP. Our report adds further genetic and clin-
ical heterogeneity to patients with JBTS and AHI1 mu-
tations, as the three novel mutations detected also lead to
loss of both the SH3 domain and part or all of the WD40
domains in each case (Fig. 2B–E). It is of note that, like
Jouberin, nephrocystin-1 has both an SH3 domain and a
coiled-coil domain; therefore, it is likely that these pro-
teins may interact within a functional complex both in the
kidney and the brain. Homozygous mutations in NPHP1
may sometimes lead to a JBTS phenotype, although this is
rare. This implies that genotype and clinical phenotype
correlations are difficult to make and that additional
proteins within the nephrocystin-1/Jouberin complex may
determine the phenotype via genetic modifiers. SH3 do-
mains typically bind to PXXP amino acid motifs [18], and
indeed the AHI1 protein contains four PXXP motifs.
Therefore, since similar truncating mutations were found
in JBTS patients with and without NPHP, the position of
the truncation does not seem to explain the presence or
absence of renal involvement. One potential explanation
could be the action of additional “modifier” genes, anal-
ogous to the related disorder Bardet-Biedl syndrome, the
clinical spectrum of which includes renal failure [19]. In
Bardet-Biedl syndrome oligogenic mutations may poten-
tiate a phenotype that is caused by two disease-causing
recessive mutations in an independent gene [19].
In conclusion, AHI1 mutations are a cause of JBTS,
and we demonstrate that novel truncating mutations are
present in an affected individual with NPHP-associated
JBTS. The role of AHI1 in renal cyst development and its
interaction with other nephrocystins will require further
investigation.
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